InvestorsHub Logo
Followers 45
Posts 6151
Boards Moderated 0
Alias Born 06/17/2009

Re: Venture_Cap post# 90553

Saturday, 07/04/2020 12:44:00 PM

Saturday, July 04, 2020 12:44:00 PM

Post# of 232331
VC, if Leronlimab were showing strong results, the Data and Safety Monitoring Board (DSMB) might step in and recommend swifter approval due to clear safety and efficacy results. Given the increases in CV-19 cases across the country, DSMB might be very interested in the drug's results so far.

https://www.nidcr.nih.gov/research/human-subjects-research/interventional-studies/data-and-safety-monitoring-board-guidelines

P.S. I would not think any announcement on HCQ, as noted earlier, would cause any market changing impact to its provider(s).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News